X
Sanofi says biotech acquisitions will help overcome diabetes decline
https://pharmaphorum.com/news/sanofi-says-biotech-acquisitions-will-help-overcome-diabetes-decline/
Bioverativ
After losing out on two big deals, Sanofi to buy Bioverativ for $11.6bn
French pharma makes move into haemophilia market.
Despite Trump price concerns, JP Morgan event anticipates M&A boom
2017 could be a bumper year for M&A – but Trump’s price control threats dominate
Biogen’s haemophilia spin-out Bioverativ to launch early 2017
Coming antibody drugs and gene therapy could transform treatment
